Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11692032 Anti-LAG3 antibodies and uses thereof

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
0
Date Filed
June 6, 2019
0
Date of Patent
July 4, 2023
0
Patent Applicant
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
0
Patent Application Number
16433263
0
Patent Citations
‌
US Patent 10358495 Anti-LAG3 antibodies and uses thereof
0
‌
US Patent 8246995 Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells
0
‌
US Patent 8257740 Pharmaceutical composition of nanoparticles
0
‌
US Patent 8551481 Anti-cancer vaccine composition comprising an anti-CD223 antibody and kit comprising an anti-cancer vaccine and an anti-CD223 antibody
0
‌
US Patent 9321832 Ligand
0
‌
US Patent 10905784 Radiolabeled anti-LAG3 antibodies for immuno-PET imaging
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11692032
0
Patent Primary Examiner
‌
Ilia I Ouspenski
0

Find more entities like US Patent 11692032 Anti-LAG3 antibodies and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.